serw-MX  [xml]  
 


    
 DeCS Categories

C04 Neoplasms .
C04.588 Neoplasms by Site .
C04.588.614 Nervous System Neoplasms .
C04.588.614.550 Paraneoplastic Syndromes, Nervous System .
C04.588.614.550.112 Anti-N-Methyl-D-Aspartate Receptor Encephalitis .
C04.730 Paraneoplastic Syndromes .
C04.730.856 Paraneoplastic Syndromes, Nervous System .
C04.730.856.112 Anti-N-Methyl-D-Aspartate Receptor Encephalitis .
C10 Nervous System Diseases .
C10.228 Central Nervous System Diseases .
C10.228.140 Brain Diseases .
C10.228.140.430 Encephalitis .
C10.228.140.430.124 Anti-N-Methyl-D-Aspartate Receptor Encephalitis .
C10.574 Neurodegenerative Diseases .
C10.574.781 Paraneoplastic Syndromes, Nervous System .
C10.574.781.249 Anti-N-Methyl-D-Aspartate Receptor Encephalitis .
C20 Immune System Diseases .
C20.111 Autoimmune Diseases .
C20.111.258 Autoimmune Diseases of the Nervous System .
C20.111.258.124 Anti-N-Methyl-D-Aspartate Receptor Encephalitis .
D02 Organic Chemicals .
D02.241 Carboxylic Acids .
D02.241.081 Acids, Acyclic .
D02.241.081.337 Dicarboxylic Acids .
D02.241.081.337.052 Adipates .
D02.241.081.337.052.075 2-Aminoadipic Acid .
D12 Amino Acids, Peptides, and Proteins .
D12.125 Amino Acids .
D12.125.067 Amino Acids, Acidic .
D12.125.067.500 Aspartic Acid .
D12.125.067.500.400 N-Methylaspartate .
D12.125.070 Amino Acids, Branched-Chain .
D12.125.070.950 Valine .
D12.125.070.950.100 2-Amino-5-phosphonovalerate .
D12.125.119 Amino Acids, Dicarboxylic .
D12.125.119.075 2-Aminoadipic Acid .
D12.125.119.170 Aspartic Acid .
D12.125.119.170.400 N-Methylaspartate .
D12.125.740 Phosphoamino Acids .
D12.125.740.025 2-Amino-5-phosphonovalerate .
D12.776 Proteins .
D12.776.157 Carrier Proteins .
D12.776.157.530 Membrane Transport Proteins .
D12.776.157.530.400 Ion Channels .
D12.776.157.530.400.400 Ligand-Gated Ion Channels .
D12.776.157.530.400.400.500 Receptors, Ionotropic Glutamate .
D12.776.157.530.400.400.500.500 Receptors, N-Methyl-D-Aspartate .
D12.776.543 Membrane Proteins .
D12.776.543.550 Membrane Glycoproteins .
D12.776.543.550.450 Ion Channels .
D12.776.543.550.450.500 Ligand-Gated Ion Channels .
D12.776.543.550.450.500.200 Receptors, Ionotropic Glutamate .
D12.776.543.550.450.500.200.500 Receptors, N-Methyl-D-Aspartate .
D12.776.543.585 Membrane Transport Proteins .
D12.776.543.585.400 Ion Channels .
D12.776.543.585.400.500 Ligand-Gated Ion Channels .
D12.776.543.585.400.500.200 Receptors, Ionotropic Glutamate .
D12.776.543.585.400.500.200.500 Receptors, N-Methyl-D-Aspartate .
D12.776.543.750 Receptors, Cell Surface .
D12.776.543.750.720 Receptors, Neurotransmitter .
D12.776.543.750.720.200 Receptors, Amino Acid .
D12.776.543.750.720.200.450 Receptors, Glutamate .
D12.776.543.750.720.200.450.400 Receptors, Ionotropic Glutamate .
D12.776.543.750.720.200.450.400.500 Receptors, N-Methyl-D-Aspartate .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
2-Aminoadipic Acid .
2 Aminoadipic Acid .
2-Aminohexanedioic Acid .
2 Aminohexanedioic Acid .
Acid, 2 Aminoadipic .
Acid, 2-Aminoadipic .
Acid, 2-Aminohexanedioic .
Acid, alpha-Aminoadipic .
Aminoadipic Acid, 2 .
alpha Aminoadipic Acid .
alpha-Aminoadipic Acid .
A metabolite in the principal biochemical pathway of lysine. It antagonizes neuroexcitatory activity modulated by the glutamate receptor, N-METHYL-D-ASPARTATE; (NMDA). .
1.00
 
Receptors, N-Methyl-D-Aspartate .
N-Methylaspartate Receptors .
Receptors, N-Methylaspartate .
N Methyl D Aspartate Receptors .
N Methylaspartate Receptors .
NMDA Receptor Ionophore Complex .
Receptors, N Methyl D Aspartate .
Receptors, N Methylaspartate .
N-Methyl-D-Aspartate Receptors .
NMDA Receptor-Ionophore Complex .
NMDA Receptors .
Receptors, NMDA .
A class of ionotropic glutamate receptors characterized by affinity for N-methyl-D-aspartate. NMDA receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which magnesium ions bind in a voltage-dependent manner. The positive voltage dependence of channel conductance and the high permeability of the conducting channel to calcium ions (as well as to monovalent cations) are important in excitotoxicity and neuronal plasticity. .
0.43
 
N-Methylaspartate .
N-Methyl-D-aspartic Acid .
Acid, N-Methyl-D-aspartic .
N Methyl D aspartate .
N Methyl D aspartic Acid .
N Methylaspartate .
N-Methyl-D-aspartate .
NMDA 17380 .
An amino acid that, as the D-isomer, is the defining agonist for the NMDA receptor subtype of glutamate receptors (RECEPTORS, NMDA). .
0.41
 
2-Amino-5-phosphonovalerate .
2-APV .
2-Amino-5-phosphonopentanoate .
5-Phosphononorvaline .
d-APV .
dl-APV .
2 Amino 5 phosphonopentanoate .
2 Amino 5 phosphonopentanoic Acid .
2 Amino 5 phosphonovalerate .
2 Amino 5 phosphonovaleric Acid .
5 Phosphononorvaline .
2-Amino-5-phosphonopentanoic Acid .
2-Amino-5-phosphonovaleric Acid .
The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors. .
0.40
 
Anti-N-Methyl-D-Aspartate Receptor Encephalitis .
Anti-NMDA Receptor Encephalitis .
Anti-NMDAR Encephalitis .
Non-paraneoplastic Anti-N-Methyl-D-Aspartate Receptor Encephalitis .
Non-paraneoplastic Anti-NMDA Receptor Encephalitis .
Non-paraneoplastic Anti-NMDAR Encephalitis .
Paraneoplastic Anti-N-Methyl-D-Aspartate Receptor Encephalitis .
Paraneoplastic Anti-NMDA Receptor Encephalitis .
Paraneoplastic Anti-NMDAR Encephalitis .
Anti N Methyl D Aspartate Receptor Encephalitis .
Anti NMDA Receptor Encephalitis .
Anti NMDAR Encephalitis .
Anti-N-Methyl-D-Aspartate Receptor Encephalitides .
Anti-NMDA Receptor Encephalitides .
Anti-NMDAR Encephalitides .
Anti-NMDAR Encephalitides, Non-paraneoplastic .
Anti-NMDAR Encephalitides, Paraneoplastic .
Anti-NMDAR Encephalitis, Non-paraneoplastic .
Anti-NMDAR Encephalitis, Paraneoplastic .
Encephalitides, Anti-N-Methyl-D-Aspartate Receptor .
Encephalitides, Anti-NMDA Receptor .
Encephalitides, Anti-NMDAR .
Encephalitides, Non-paraneoplastic Anti-NMDAR .
Encephalitides, Paraneoplastic Anti-NMDAR .
Encephalitis, Anti-N-Methyl-D-Aspartate Receptor .
Encephalitis, Anti-NMDA Receptor .
Encephalitis, Anti-NMDAR .
Encephalitis, Non-paraneoplastic Anti-NMDAR .
Encephalitis, Paraneoplastic Anti-NMDAR .
Non paraneoplastic Anti N Methyl D Aspartate Receptor Encephalitis .
Non paraneoplastic Anti NMDA Receptor Encephalitis .
Non paraneoplastic Anti NMDAR Encephalitis .
Non-paraneoplastic Anti-NMDAR Encephalitides .
Paraneoplastic Anti N Methyl D Aspartate Receptor Encephalitis .
Paraneoplastic Anti NMDA Receptor Encephalitis .
Paraneoplastic Anti NMDAR Encephalitis .
Paraneoplastic Anti-NMDAR Encephalitides .
Receptor Encephalitides, Anti-NMDA .
Receptor Encephalitis, Anti-NMDA .
Disorder characterized by symptoms of CATATONIA; HYPOVENTILATION; DYSKINESIAS; ENCEPHALITIS; and SEIZURES followed by a reduced CONSCIOUSNESS. It is often followed by a viral-like prodrome. Many cases are self-limiting and respond well to IMMUNOMODULATORY THERAPIES against the NMDA RECEPTORS antibodies. .
0.39